January 11, 2017

21 CFR Part 11 (Electronic Record/Electronic Signature) Compliance for Computer Sys Regulated by FDA

IndiaProduction

IndiaProduction

Recommended Reports

Tyrosine Protein Phosphatase Non Receptor Type 11 (Protein Tyrosine Phosphatase 1D or Protein Tyrosine Phosphatase 2C or SHP2 or SHPTP2 or SH PTP3 or PTPN11 or EC 3.1.3.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Squalene Monooxygenase (Squalene Epoxidase or SQLE or EC 1.14.14.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Atrial Natriuretic Peptide Receptor 1 (Atrial Natriuretic Peptide Receptor Type A or Guanylate Cyclase A or NPR1 or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

View All

More

Medical Technology UK 2023

International congress on pediatrics neonatal and nursing care, Prague

Outsourcing in Clinical Trials: Medical Devices USA 2023

Outsourcing in Clinical Trials West Coast (& device stream) 2023